#LCSM Chat Topic 10/04/2018: Highlights from #WCLC2018

After a summer hiatus, #LCSM Chat is returning to Twitter!  Our first chat of the fall will be on Thursday, October 04, at 5pm Pacific Time (8 pm Eastern).  We will be reviewing key presentations from the IASLC 19th World Conference on Lung Cancer (#WCLC2018) held September 23-26 in Toronto, Canada.  Our special guests for this chat will be the Communications Team from the International Association for the Study of Lung Cancer (IASLC), the organizers of WCLC, and our moderator will be Janet Freeman-Daily (@JFreemanDaily). WCLC abstracts may be oral presentations (20… Read More

#LCSM Chat topic 6/14/2018: Immunotherapy–the ultimate personalized therapy

Immunotherapy has revolutionized cancer care, particularly for lung cancer patients.  On Thursday, June 14, 2018, at 8 PM Eastern time (5 PM Pacific), #LCSM Chat moderator Brendon Stiles (@BrendonStilesMD) will lead our discussion on “Immunotherapy–the ultimate personalized therapy.” Over the last few years, several “checkpoint inhibitors” have been approved by the FDA for lung cancer patients.  Because these drugs essentially unleash brakes on T cells which allow each patient’s own immune system to kill their cancer cells, these drugs could be considered the ultimate personalized therapy for cancer.  In fact, these drugs… Read More

#LCSM Chat 5/31/18: Lung Cancer at ASCO 2018

For the upcoming #LCSM chat on Thursday, 5/31 at 8 PM Eastern (5 PM Pacific), we’re going to preview some of the key abstracts in lung cancer and mesothelioma that will be presented at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago in early June. This meeting brings together over 38,000 cancer specialists every year to review thousands of presentations. Nobody can see it all, and one important aspect of not being overwhelmed is knowing what should be the focus of your attention. Dr. Jack West has compiled two… Read More